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The Sonic hedgehog signaling (Shh) pathway plays a crucial role in cell 
proliferation and differentiation via Patched1 (Ptc1), a twelve-pass transmembrane 
receptor protein. Recently, it was shown that the extracellular domain of Ptc1 functions 
as a binding site for its ligand, Shh. However, the roles of its intracellular domains 
remain a mystery to date.  
 In this study, it was focused on the importance of the C-terminal region of 
endogenous Ptc1 7th intracellular domain (ICD7) in mammalian cells. A specific 
antibody was prepared and could recognize 15 residues in the C-terminal region of 
ICD7. This antibody detected endogenous Ptc1 protein that was cleaved at the 
C-terminal region in mammalian cells. As a result, translocation of ICD7 fragments 
into the nucleus was observed. Contrary to this finding for endogenous ICD7 
fragments, overexpressed ICD7 fragments accumulated in the cytoplasm. To resolve 
this discrepancy, ICD7 expression was controlled by using the Tet-On Advanced 
system, whose promoter activity can be regulated by modulating the concentration of 
doxycycline (Dox). As a result, the processing pattern and nuclear localization of ICD7 
were greatly modulated in a Dox concentration-dependent manner. 
 Next, to clarify the role of Ptc1 ICD7, a screening was subsequently 
performed for Ptc1 ICD7-binding proteins by mass spectrometry. As a result, 81 
different candidate binding proteins were identified. I was interested in my finding that 
almost one-quarter of the candidate binding proteins were ubiquitin-related enzymes, 
including several E3 ubiquitin ligase subunits. Therefore, I examined the function of 
ICD7 from the viewpoint of ubiquitination. As a result, ICD7 and some E3 ubiquitin 
ligase proteins were found to interact in cultured cells, including ZYG11B, TCEB1, 
TCEB2, and Cullin-2 (CUL2), all of which have been shown to constitute an ECS-type 
E3 ligase complex. Moreover, gel filtration analysis demonstrated that ICD7, ZYG11B, 
2 
 
TCEB1, TCEB2, and CUL2 were eluted as a large complex. These results show the 
novel association of the CUL2-based E3 ubiquitin ligase complex with Ptc1 ICD7. To 
address the function of CUL2-based E3 ligase in the Shh signaling pathway, I 
examined the effects of CUL2 knockdown on Shh-induced osteoblast differentiation in 
the mesenchymal stem cell line C3H10T1/2. Measurement of alkaline phosphatase 
activity, which is a marker of osteoblast differentiation, showed the decrease of 
Shh-induced osteoblast differentiation in CUL2 knockdown cells compared with 
control. These results suggest that the CUL2-based E3 ligase complex may play a role 
in Shh- and Ptc1-dependent signaling pathways. 
 Finally, I investigated the mechanism of Ptc1 ICD7 nuclear localization. 
AKIP1, which was identified as a novel binding protein of ICD7 in this study, is 
reportedly an associated protein of NF-B for nuclear targeting. The activity of the 
transcription factor Gli1 was found to be increased when ICD7 was co-expressed with 
AKIP1 under the condition of ICD7 nuclear localization in Tet-On HeLa cells. 
Additionally, inhibition of the expression of endogenous AKIP1 resulted in the 
suppression of ICD7 nuclear transport, suggesting that AKIP1 contributes to the 





All organisms have signal transduction machineries, and many of them are 
controlled through specific membrane-bound receptor proteins. The Sonic hedgehog 
(Shh) signaling pathway regulates diverse processes involved in stem cell growth, 
maintenance and differentiation [Tabata and Kornberg, 1994]. Shh, which is also 
known as an extracellular morphogen, transmits information to target cells through the 
receptor protein Patched1 (Ptc1), which is a 12-pass transmembrane protein, that is 
largely localized in cilia and the endosome membrane fraction. Ptc1 has two large loop 
structures that are located extracellularly, which serve as a ligand-binding domain (Fig. 
1). The 4th and 7th intracellular domains also constitute a large part of Ptc1 (Fig. 1); 
however, the function of the intracellular domains is currently enigmatic, whereas the 
role of the extracellular domain as a ligand-binding domain has been identified clearly. 
Shh signaling pathway involves two key proteins, the Shh receptor Ptc1 and a 
downstream oncogenic transcription factor, Gli1. In the absence of Shh, Ptc1 represses 
Gli-dependent transcription through indirect inhibition of another transmembrane 
protein, Smoothened (Fig. 2a). Binding of Shh to Ptc1 alleviates this repression, 
allowing activation of the Gli-mediated cell differentiation pathway (Fig. 2b) [Ingham 
and McMahon, 2001; Marigo et al., 1996; Ingham et al., 2000]. 
 In humans, ptc1 acts as a tumor suppressor gene, as shown by the presence of 
inactivating mutations in ptc1 in sporadic and inherited forms of the common skin 
tumor basal cell carcinoma [Gailani et al., 1996; Hahn et al., 1996; Johnson et al., 
1996] and brain tumors [Vorechovsky et al., 1997; Xie et al., 1997]. There are two 
major classes of Ptc1 mutant type that induce oncogenesis. One is a truncated type 
mutation, which is caused by nonsense or frameshift mutations, resulting in 
inactivation of Ptc1 and aberrant activation of the Gli transcription factor, thus 
inducing cancer development (Fig. 3a). The other type of mutation, that is, a point 
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mutation in the ligand binding region of the extracellular domain, destroys the ligand 
binding ability of the extracellular domain (Fig. 3b). These mutations reportedly result 
in defects in the Shh signaling pathway, and eventually induce oncogenesis. In the case 
of the intracellular domains of Ptc1, dozens of mutation in the 7th intracellular domain 
(ICD7) of Ptc1 have been linked to cancer development (Fig. 3c). These reports 
suggest the importance of the Ptc1 intracellular domains in Shh signaling pathway 
during cell proliferation and differentiation. Despite its biological importance, the 
intracellular signaling pathway mediated by mammalian Ptc1 ICD7 still remains 
largely elusive.  
 In Caenorhabditis elegans, the Gli-family Krüppel-like zinc finger 
transcription factor TRA-1 is regulated indirectly by TRA-2, a Ptc1-related 12-pass 
transmembrane protein, and TRA-1 activation results in female-specific cell 
differentiation (Fig. 4) [Kuwabara and Kimble, 1992; Zarkower, 2006]. Genetic 
epistasis analysis suggests that tra-2 is an upstream regulator of three tra-1 suppressor 
genes, fem-1, fem-2, and fem-3 [Goodwin and Ellis, 2002]. Interestingly, Mehra et al. 
reported that the C-terminal cytoplasmic tail of TRA-2 (hereafter designated as TRA-2 
ICD7) interacts directly with the cytoplasmic protein FEM-3 and prevents 
male-specific TRA-1 suppression in somatic tissues (Fig. 4) [Mehra et al., 1999; Lum 
et al., 2000]. This finding indicates that TRA-2 ICD7 has transcriptional regulatory 
activity for controlling TRA-1-mediated cell differentiation by modulating FEM family 
proteins. It was revealed recently that the three FEM proteins form a ubiquitin ligase 
complex for TRA-1 degradation [Starostina et al., 2007]. 
 In a previous study, Kagawa et al. developed a stable HeLa cell line 
transfected with an expression vector encoding human full-length Ptc1 that was with 
N-terminally and C-terminally-tagged. The N-terminally T7-tagged Ptc1 fraction was 
detected at endosomes, which is the archetypal localization pattern for Ptc1 [Kagawa et 
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al., 2011]. Conversely, the signal for C-terminally FLAG-tagged Ptc1 was found in the 
nucleus. These results suggested that the C-terminal fragment was cleaved off from 
exogenous full-length Ptc1, and that this fragment can be localized in the nucleus. On 
the other hand, the nuclear localization of ICD7 fragments which are produced by 
cleavage of endogenous Ptc1 ICD7, has not been reported, and hence I focused on 
endogenous Ptc1 ICD7 in mammalian cells. In this thesis, to elucidate the presence of 
the Ptc1 ICD7 fragment, I developed an antibody specific to human and mouse Ptc1 
ICD7. Using this antibody, the nuclear localization of ICD7 was investigated in 
Chapter 1. 
In Chapter 2, I subsequently screened for Ptc1-binding proteins by mass 
spectrometry to investigate the role of Ptc1 ICD7. I found that ICD7 was associated 
with a number of ubiquitin-related proteins. I provided evidence that the CUL2-based 
complex is closely associated with Ptc1 in cells, both physically and functionally. In 
Chapter 3, I further focused on a previously uninvestigated ICD7-binding protein. A 
kinase interacting protein AKIP1 was reported originally by Mille et al. as a candidate 
binding protein of Ptc1 ICD7, but its function in the Shh pathway has been reported 






Figure 1. Ptc1 is a receptor protein for Shh 
Ptc1 is a 12-pass transmembrane protein that is largely localized in the endosome 
membrane fraction. Ptc1 has two large extracellular loop structures, which serve as a 
ligand-binding domain (show as green). The 4th and 7th intracellular domains form a 
large part of Ptc1 (shown in red). 
 
Figure 2. Shh signaling pathway for cell proliferation and differentiation 
(a) Ptc1 suppresses the activity of Smo in the absence of Shh signaling.  
(b) The suppression of Smo by Ptc1 is abrogated by the binding of the secreted protein 
Shh to Ptc1, which facilitate the activation of the downstream transcription factor Gli1.  
 
Figure 3. Human oncogenic mutation types of Ptc1 
(a) Truncations of human Ptc1 protein caused by nonsense- or frameshift-mediated 
oncogenic mutations.  
(b) A representative point-mutation in the extracellular domain of Ptc1. These 
mutations reportedly destroy the ability of Ptc1 to bind Shh. Malfunction of the 
signaling pathway causes carcinogenesis.  
(c) Mutations in the intracellular domain of Ptc1. These mutations are reportedly 
linked with oncogenesis, while the carcinogenic mechanism is unknown. 
 
Figure 4. Function of the 7th intracellular in TRA-2, nematode homolog of Ptc1 
The 12-pass transmembrane protein TRA-2 is cleaved at the C-terminal intracellular 
domain, resulting in the nuclear translocation of ICD7 fragments. This translocation of 
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CHAPTER 1: C-terminal fragments of mammalian Patched1 are 
transported to the nucleus 
 
Summary 
A previous study indicated that TRA-2, Caenorhabditis elegans homolog of 
human Patched1 (Ptc1), is cleaved just under the plasma membrane and the fragments 
translocate to the nucleus to activate the downstream Gli1-related transcription factor 
TRA-1. Following this finding, Kagawa et al focused on the 7th intracellular domain 
(ICD7) of mammalian Ptc1 and established a cell line stably expressing full-length 
human Ptc1 in HeLa cells. With this cell line, Kagawa et al. reported that extrinsic Ptc1 
proteins can be cleaved at the C-terminal region, and thus resulted in the production of 
ICD7 fragments, which are subsequently translocated to the nucleus. However, it 
remains obscure whether the cleavage and nuclear translocation of endogenous the 
Ptc1 ICD7 domain occur. 
Referring to the results of previous studies, I initially examined endogenous 
Ptc1 in mammalian cell culture. First, I prepared an antibody that recognizes 15 
residues in the C-terminal of human and mouse Ptc1 to assess the nuclear translocation 
of endogenous ICD7 fragments. I provided evidence that this antibody reacts with Ptc1 
ICD7 specifically by competition experiments with the corresponding antigenic 
peptide. Next, the localization of endogenous Ptc1 ICD7 in mammalian cells was 
analyzed using a fluorescence-based immunochemical method. According to this 
experiment, endogenous Ptc1 ICD7 fragments were found to localize in the nucleus of 
HeLa cells and mouse primary culture cells. I found that the nuclear localization of 
Ptc1 ICD7 was modulated by its expression level. Moreover, I found that the nuclear 





 The downstream pathway of Sonic hedgehog (Shh) and Patched1 (Ptc1) 
involves two key proteins, the oncogenic transcription factor Gli and the 
transmembrane protein Smoothened (Smo) [Ingham and McMahon, 2001; Riobo and 
Manning, 2007; Varjosalo and Taipale, 2007]. In the absence of Shh, Ptc1 represses 
Gli-dependent transcription through Smo inhibition [Marigo et al., 1996; Ingham et al., 
2000]. Extracellular domains of Ptc1 are essential for accepting its ligand, Shh, and 
binding of Shh alleviates Smo repression, causing activation of Gli1-dependent 
transcription. In contrast to the understanding of extracellular domain functions, the 
role of the intracellular domain (ICD) of Ptc1 is rather obscure. Several previous 
studies imply that the C-terminal end of Ptc1, the 7th and largest intracellular domain 
(ICD7), is also functional. Ptc, Drosophila homolog of Ptc1, ICD7 was required for 
appropriate regulation of the Hedgehog (Hh) signaling pathway [Johnson et al., 2000; 
Lu et al., 2006], and deletion of the C-terminal 156 residues of Drosophila Ptc was 
shown to compromise Hh target gene repression [Johnson et al., 2000]. A spontaneous 
mouse mutant encoding a C-terminally truncated Ptc1 protein [Sweet et al., 1996; 
Makino et al., 2001] showed defects in A-P polarity of the limb bud, and demonstrated 
increased expression of Shh target genes in white fat tissue [Makino et al., 2001]. 
Furthermore, polymorphic variation of Ptc1 ICD7 at T1267 was shown to be essential 
for susceptibility to H-ras-induced squamous carcinoma [Wakabayashi et al., 2007]. In 
humans, it was revealed that several oncogenic mutations of Ptc1 map to positions 
corresponding to the ICD7 region [Gailani et al., 1996; Lench et al., 1997; Boutet et al., 
2003; Savino et al., 2004]. These findings highlight the functional importance of Ptc1 
ICD7 in the Hh-mediated signal transduction pathway, though the exact mechanism of 
Ptc1 ICD7 remains unclear. 
 In Caenorhabditis elegans, the transcriptional activity of TRA-1, a single 
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homolog of the mammalian Gli transcriptional factors, is regulated by the tra-2 gene 
product [Bürglin and Kuwabara, 2006; Zarkower and Hodgkin, 1992; Zarkower, 2006] 
and, indeed, TRA-2 and human Ptc1 share several similar characteristics. They are 
both twelve-passed transmembrane (TM) proteins (General introduction Fig.1, Fig. 4), 
with TM domains arranged in two sets of (1+3+2) membrane spanning domains 
reminiscent of some RND-family transporters [Varjosalo and Taipale, 2007]. TRA-2 is 
a receptor for secreted glycoprotein HER-1 and modulates the transcriptional activity 
of TRA-1. The ICD7 of TRA-2 is located at the C-terminus (General introduction Fig. 
4). Interestingly, several studies indicate that TRA-2 ICD7 has its own biological 
activity. First, an alternative spliced transcript of tra-2, named tra-2b, was identified in 
germline cells of hermaphrodites, and shown to encode a TRA-2 ICD7 fragment 
[Okkema and Kimble, 1991]. Second, Lum et al. (2000) reported that forced 
expression of exogenous tra-2b results in the predominant localization of TRA-2 ICD7 
fragment in the nuclei of somatic cells, and causing complete somatic feminization of 
XO animals [Lum et al., 2000]. This indicates that TRA-2 ICD7 fragment has 
transcriptional regulatory activity in the nucleus. Third, Kuwabara and co-workers 
demonstrated that proteolytic cleavage by calpain-like protease TRA-3 generates a 
soluble ICD7 fragment from the membrane-bound form of TRA-2 [Sokol and 
Kuwabara, 2000]. Furthermore, Shimada et al. previously found that the endogenous 
TRA-2 ICD7 fragment accumulates in the nucleus where it stimulates female-specific 
transcription in hermaphrodites [Shimada et al., 2006]. These observations indicate 
that the generation and translocation of the TRA-2 ICD7 fragment into the nucleus is a 
biologically relevant event in transcriptional regulations in the case of nematodes.  
 In this study, I provide conclusive evidence that C-terminal fragments of 
endogenous Ptc1 accumulate in the nucleus in a wide variety of mammalian cells. 
From these observations, I suggest the existence of a novel alternative signaling 
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pathway for mammalian Ptc1 that is mediated by the generation and nuclear 
translocation of ICD7 fragments.   
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Material and Methods 
Mammalian cell culture and transfection 
 HeLa cell [Minami et al., 2010] was cultured in Dulbecco's modified Eagle's 
medium (Sigma Chemical Co., St Louis, MO) supplemented with 10% heat-inactivated 
Calf Serum at 37°C under a 5% CO2 atmosphere. Mouse C3H10T1/2 cells and 
embryonic primary cells were cultured as is HeLa cells except for the usage of 10% 
heat-inactivated Fetal Calf Serum. 
 Transfection of the expression vectors to HeLa cells were performed with 
HilyMax transfection reagent (Dojindo, Japan) according to the protocol supplied by 
the manufacturer. The total amount of plasmid DNA was adjusted to 1 g with an 
empty vector. At 24 hr after transfection, the cells were harvested and subjected to 
immunological analysis unless otherwise noted. 
 
Immunological analysis 
 The anti-Ptc1 ICD7 C-terminal antibody (designated anti-Ptc ICD7 
(1420-1434) antibody) was prepared for this study as follows. The antigenic peptide 
used in this study corresponds to human Ptc1 C-terminal amino acids sequence 
1420-1434 (CERRDSKVEVIELQD) that is a region specific to Ptc1 among the 
predicted human protein sequences from the genome database. Immunization to the 
rabbit with 0.3 mg antigenic peptide was performed for six times at two-week intervals 
by Operon Biotechnologies (Tokyo, Japan). The antibody was successively purified 
with Protein A-Sepharose and antigenic peptide affinity chromatography. Antigenic 
sequence is completely conserved between human and mouse, and I confirmed that the 
antibody thus obtained can efficiently recognize both of human and mouse Ptc1. 
 For Western blot analysis, the whole cell lysate and immunoprecipitates were 
separated by SDS-PAGE and transferred onto PVDF membranes (GE Healthcare). The 
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membranes were probed with specific antibodies as indicated and then incubated with 
horseradish peroxidase-conjugated antibody against mouse and rabbit immunoglobulin 
(GE Healthcare), followed by detection with ECL Western blotting detection reagents 
(GE healthcare). 
 The following antibodies were used for immunological analyses in this study: 
anti-FLAG polyclonal (Sigma), anti-FLAG M2 monoclonal (Sigma), anti-Ptc-ICD7 
C-terminal (1420-1434) (prepared in this study), anti-human Ptc1 SSD (500-600) 
(Abcam, Cat. No. ab39266), anti-actin polyclonal (Sigma), anti-S tagR polyclonal 
(Santa Cruz), HRP-conjugated anti-rabbit IgG (GE healthcare), and HRP-conjugated 
anti-mouse IgG (GE healthcare). 
 
Microscopic observations 
 For immunocytochemical observations of cultured cells, cells were grown on 
micro coverglass (Matsunami, Japan), fixed by incubating in 4% paraformaldehyde, 
and were then permeabilized with 0.1% Triton X-100. Fixed cells were blocked with 
3% calf serum in PBS and reacted with a series of primary antibodies at room 
temperature for one hour. For examples, affinity-purified anti-Ptc-ICD7 C-terminal 
(1420-1434) antibody was diluted to a concentration of 5.5 nM (about 0.8 g/mL) 
before incubation. For peptide competition experiments, an antigenic peptide was used 
at concentrations of 1.2 M or 0.6 M. Anti-T7 tag and anti-FLAG tag antibodies were 
used at 15 nM. Alexa™ 488-conjugated anti-rabbit IgG antibody and Alexa™ 
594-conjugated anti-mouse IgG antibody (Molecular Probes) were used as secondary 
antibodies at 1∶800 dilution. To observe the nucleus, cells were treated with 2.5 g/ml 
Hoechst 33342 or DAPI for 15 minutes at 25°C and then washed another three times in 
PBS-T. Immunofluorescent images were obtained with BIOREVO BZ9000 
fluorescence microscope (Keyence, Japan) and an LSM510 invert confocal microscopy 
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system (Carl Zeiss, Germany). 
 
 
DNA recombination experiments: The study was approved by the Research Ethics and 
Safety Committee of Tokyo Metropolitan University (approval number, 27-35). All 




Establishment of a specific antibody for the C-terminus of Ptc1 
 The cellular behavior of endogenous Ptc1 ICD7 fragments in mammalian cells 
is enigmatic as an appropriate C-terminal specific antibody had not been available. I 
therefore newly established a polyclonal antibody to a synthetic peptide (1420- 
CERRDSKVEVIELQD -1434) that is derived from the C-terminal sequence of human 
Ptc1 ICD7 (Fig. 1a, b). It should be noted that the antigenic sequence is completely 
conserved between human and mouse (Fig. 1a), thus it can be applicable for both of 
these species. I designate this newly established polyclonal IgG as anti-Ptc1 ICD7 
(1420-1434) antibody. I next examined endogenous Ptc1 protein in C3H10T1/2 cells, 
mouse embryonic fibroblast cells that have the potential to undergo osteoblast 
differentiation in response to Shh [Kinto et al., 1997; Murone et al., 1999; Zehentner et 
al., 2000; Spinella-Jaegle et al., 2001], indicating that the Ptc1-dependent signaling 
pathway is active in this cell line. I verified the expression of endogenous Ptc1 protein 
in this cell line with a commercially available antibody. Western blot analysis of 
mammalian cells, HeLa and C3H10T1/2, lysates with an anti- Ptc1-SSD antibody that 
recognizes the sterol-sensing domain (SSD, residues 500-600 of Ptc1, Fig. 2a, b) of 
mammalian Ptc1 reacted with signal correspond to full-length form of Ptc1 (Fig. 2a, b, 
right lane, indicated by an arrow). In identical conditions, I found that the anti-Ptc1 
ICD7 (1420-1434) antibody detected a 37-kDa signal that might correspond to the 
endogenous ICD7 fragment of mouse Ptc1 (Fig. 2a, b, left lane, indicated by an 
arrowhead). This signal was completely absorbed by the addition of excess peptide 
corresponding to the antigen, indicating that the signal is specific (Fig. 2a, b, central 
lane). For an unknown reason, I could not detect any endogenous signals that 
correspond to the full-length form of mouse Ptc1 in C3H10T1/2 cells with anti-Ptc1 
ICD7 (1420-1434) antibody. 
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Endogenous Ptc1 ICD7 fragments can be detected in the nucleoplasm of 
mammalian cells  
 I next examined the subcellular localization of endogenous Ptc1 protein in 
HeLa and C3H10T1/2 cells. Immunocytochemical staining of HeLa and C3H10T1/2 
cells with antibody that specifically recognizes the SSD domain showed punctate 
cytoplasmic staining that would be expected for intracellular endocytic membrane 
vesicles (Fig. 4c, d). These patterns are consistent with the previously reported cellular 
localization of full-length Ptc1 [Karpen et al., 2001; Strutt et al., 2001; Incardona et al., 
2002]. By contrast, immunosignals of the anti-Ptc1 ICD7 (1420-1434) antibody at a 
final concentration of 5.5 nM showed clear nuclear staining (Fig. 3a, b, Fig. 4a, b), 
suggesting that endogenous fragments of Ptc1 ICD7 can be transported into the 
nucleus. I also provide evidence that C-terminal fragments from endogenous Ptc1 
accumulate not only in the nuclei of cultured cell lines but also in that of mouse 
primary cells from 14 dpc embryos (Fig. 5a, b). These observations indicating that the 
nuclear localization of Ptc1 ICD7 could be a general event, although strength of 
nuclear signals was varied from cell to cell in the case of mouse primary cells (Fig. 5a). 
These nuclear staining were specific to Ptc1 protein, as immunostaining with 
non-immune control IgG (Fig. 3e, f, Fig. 4e, f, Fig. 5e, f). To further evaluate antibody 
specificity for nuclear staining, I performed an antigen competition assay. By 
absorption using excess amounts of antigenic peptide (at a final concentration of 1.2 
M peptide), I confirmed that immuno-signals of the anti-Ptc-ICD7 (1420-1434) 
antibody (at a final concentration of 5.5 nM IgG) in the nucleus of C3H10T1/2 cells 
were completely abolished (Fig. 6a-d). Similarly, nuclear immunosignals in embryonic 
primary cells were abolished with the 0.6 M antigenic peptide competition (Fig. 6e-h). 
Together, these results indicate that the anti-Ptc1 ICD7 (1420-1434) antibody 
specifically and exclusively recognized corresponding target fragments in the nucleus. 
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I therefore suggest a novel signaling mechanism for mammalian Ptc1 that is mediated 
by the generation and nuclear translocation of C-terminal ICD7 fragments. 
 
Ptc1 ICD7 modulates the nuclear localization of Gli1 
 In a previous study, Kobayashi raised the question of why the forced 
expression of the C-terminally-FLAG-tagged Ptc1 ICD7 fragment in HeLa cells 
resulted in its cytoplasmic aggregation and the its failure to accumulate in the nucleus 
(unpublished observations). It was speculated that the difference in protein expression 
levels between the viral promoter-driven (with an expression plasmid) and endogenous 
conditions gave rise to the difference in the cellular localization of ICD7. Indeed, 
Kobayashi et al. found that reducing the synthesis rate of Ptc1 ICD7 by the adding of 
the protein synthesis inhibitor cycloheximide (0.4 mg/mL) clearly induced the nuclear 
translocation of the Ptc1 ICD7 fragment. To manipulate the expression level of ICD7 
accurately, I used the Tet-On Advanced system, in which the expression level of Ptc1 
ICD7 was regulated by modulating the concentration of doxycycline (Dox). The 
Tet-On Advanced system expressed Ptc1 ICD7 at the basal level in the absence of Dox 
(Fig. 7a), while the binding of Dox to the Tet-On promoter stimulated Ptc1 ICD7 
expression (Fig. 7b). Immuno-blotting of Ptc1 ICD7 with a final concentration of Dox 
at 0, 0.01, 0.1, or 1 g/mL showed variation in the signal of ICD7 (Fig. 8). ICD7 was 
detected as a 34-kDa band, which is smaller than full-length ICD7, in the absence of 
Dox. Conversely, full-length ICD7 or several processed fragments were detected 
instead of the 34-kDa signal, as the Dox concentration was increased. All of the bands 
could only be detected when HeLa cells were transfected with the ICD7 expression 
vector, suggesting that these bands are specific to ICD7. These results suggested that 
the processing pattern of Ptc1 ICD7 was influenced by its expression level. 
 Next, I examined the difference of ICD7 localization under 0 or 1 g/mL Dox 
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in Tet HeLa cells that were transfected with the ICD7 expression vector (Fig. 9). 
Over-expressed ICD7 accumulated in the cytoplasm with 1 g/mL Dox (Fig. 9a-c), 
whereas a nuclear-specific ICD7 signal was detected in the absence of Dox (Fig. 9d-f). 
As expected, the nuclear signal was never detected regardless of Dox concentration in 
the absence of expression vector transfection (Fig. 9g-l). These results indicated that 
there might exist an optimum expression level of ICD7 for its nuclear localization, and 
the excess production of ICD7 fragments resulted in their cytoplasmic accumulation. 
 To examine the function of the nuclear ICD7 fragments, I collaborated with 
Mr. Demizu to test whether the transcription factor Gli1 was influenced by the 
presence of nuclear ICD7. After the introduction of S-tagged Gli1 to Tet HeLa cells, 
exogenously-expressed Gli1 protein was detected in the cytoplasm using an anti-S-tag 
antibody (Fig. 10a, c). This observation was consistent with the previously reported 
localization of the inactive form of Gli1. Both I and Mr. Demizu co-expressed Gli1 and 
ICD7 in Tet HeLa cells in presence of 1 g/mL Dox, and we found that they were 
localized in both the cytoplasm and nucleus (Fig. 10e, f). I confirmed Mr. Demizu’s 
finding that Gli1 localized to the nucleus concomitant with the nuclear localization of 
ICD7 in the absence of Dox (Fig. 10g, h). I also showed that Gli1 was not transported 
into the nucleus without transfection of the ICD7 expression vector (Fig. 10b, d). All of 
these results suggested that the nuclear localization of Ptc1 ICD7 affected the 





 In this study, endogenous Ptc1 ICD7 was subjected to cleavage, resulting in 
the generation of soluble ICD7 fragments in human cells. This fragment was 
transported to the nucleus in not only human cells but also in mouse mesenchymal 
stem cells (C3H10T1/2). These results demonstrated the universality of the nuclear 
accumulation of ICD7 in mammalian cells. In addition, the accumulation of ICD7 in 
mouse primary culture cells demonstrated nuclear localization in a similar condition to 
that within an organism. Primary cultures that are freshly-collected from living 
organisms are expected to demonstrate similar behavior to cells in the original 
organism. Although the signal of anti-SSD antibody as full length of Ptc1 were not 
recognized the C-terminal antibody, the nuclear signals were completely abolished by 
0.6 M antigenic peptide competition; hence, the anti-Ptc1 C-terminal antibody 
detected a specific signal for endogenous ICD7. 
 In C. elegans, sex determination is regulated by the TRA-2-mediated pathway, 
which transduces a signal from the extracellular secreted factor HER-1 to the nuclear 
transcription factor TRA-1 [Kuwabara et al., 1992; Zarkower, 2006]. TRA-2, a 
homolog of human Ptc1, is a receptor for HER-1. TRA-2 binds to FEM-3, which is 
part of an E3 ubiquitin protein ligase complex, and then the activity of FEM-3 is 
inhibited by TRA-2. As a result, the transcription factor TRA-1 is activated indirectly 
by TRA-2. TRA-2 is also cleaved by an unidentified protease, resulting in the 
production of TRA-2 fragments. These TRA-2 ICD7 fragments are reportedly 
transported to the nucleus and activate TRA-1 [Shimada et al., 2006]. These results 
imply that endogenous Ptc1 ICD7 might regulate the activity of a nuclear transcription 
factor.  
 Shh reportedly binds with Ptc1, and subsequently liberates Smoothened from 
Ptc1-mediated inhibition, stimulates processing of cytoplasmic Gli1 and modulates 
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Gli1 activity [Alcedo et al., 1996; van den Heuvel et al., 1996]. I speculate that the 
nuclear Ptc1 ICD7 fragments may interact with Gli1, the most downstream factor in 
the Shh pathway. In a previous study, Kagawa et al. established a cell line stably 
expressing full-length Ptc1. C-terminal-tagged Ptc1 fragments showed a nuclear 
localization, whereas the N-terminal region remained on the cell membrane fractions 
[Kagawa et al., 2011]. It was shown that nuclear ICD7 in this stable cell line 
suppressed Gli1, a nuclear transcription factor, in previous experiments using a 
dual-luciferase reporter assay. This repression function of ICD7 is comparable to that 
of full-length Ptc1.  
 The nucleoplasm Ptc1 ICD7 were effected by its protein expression level (Fig. 
11). And what is more the Gli1 localization was influenced by ICD7 nuclear 
localization. It was reported that the nucleoplasm Gli1 was inhibited by binding with 
Suppressor-of-used (Sufu), which impeded the importing of Gli1 [Kogerman et al., 
1999; Oh et al., 2015]. Gli protein level was regulated by Sufu independently of cilia 
[Chen et al., 2009]. These results suggest that the phenomenon of nuclear localization 





Figure 1. Anti-Ptc1 C-terminal antibody could detect both human and mouse 
antigen 
(a) The antigenic sequence of the antibody used in this study was derived from the 
C-terminal region of human Ptc1, from 1420 to 1434 residues. An anti-SSD antibody, 
which react with amino acids from 500 to 600 residues, was used as a control. 
Antigenic sequence of anti-Ptc1 ICD7 (1420-1434) antibody is indicated by red. 
Identical residues in humans and mice are indicated by dots. 
(b) The amino acid sequence of the antigenic region was conserved across species. 
 
Figure 2. Immuno-blotting using the anti-Ptc1 ICD7 antibody 
The results of immuno-blotting with the anti-Ptc1 ICD7 antibody. Arrowheads show 
Ptc1 ICD7 fragments. In the case of the anti-SSD antibody, the arrow indicates 
full-length Ptc1 and the asterisks indicate the uncharacterized signals.  
(a) Immuno-blotting with extracts from HeLa cells. The anti-Ptc1 ICD7 antibody 
reacted with approximately 50-kDa and 10-kDa bands.  
(b) Immuno-blotting with extracts C3H10T1/2 cells. the anti-Ptc1 ICD7 antibody 
reacted with approximately 37-kDa and 10-kDa. 
 
Figure 3. Cellular localization of endogenous Ptc1 in human HeLa cells 
Immunostaining with the anti-Ptc1 C-terminal antibody (a), anti-SSD antibody (c), and 
non-immune serum (e). The anti-SSD antibody showed staining with an endosome-like 
distribution pattern across the cytoplasm, and the non-immune serum did not any 
detect signals, whereas the C-terminal antibody reacted with nuclear proteins. 




Figure 4. Cellular localization of endogenous Ptc1 in mouse C3H10T1/2 cells 
Immunostaining with the anti-Ptc1 C-terminal antibody (a), anti-SSD antibody (b), and 
non-immune serum (c). The anti-SSD antibody showed staining with an endosome-like 
distribution pattern across the cytoplasm, and the non-immune serum did not detect 
any signals, whereas the C-terminal antibody reacted with nuclear proteins. The 
antigenic sequence is completely conserved between human and mouse. 
Immunostaining in green and Hoechst DNA stain in blue (b, d, f). Scale bar, 20 mm.  
 
Figure 5. Cellular localization of endogenous Ptc1 in mouse embryonic primary 
cells 
Immunostaining with the anti-Ptc1 C-terminal antibody (a), anti-SSD antibody (b), and 
non-immune serum (c). The anti-SSD antibody showed staining with an endosome-like 
distribution pattern across the cytoplasm, and the non-immune serum did not detect 
any signals, whereas the C-terminal antibody reacted with nuclear proteins. 
Immuno-staining in green and Hoechst DNA stain in blue (b, d, f). Scale bar, 20 mm. 
 
Figure 6. Antigenic peptide competition experiments 
An antigenic peptide was used at concentrations of 1.2 M or 0.6 M. By absorption 
using excess amounts of antigenic peptide (at a final concentration of 1.2 M peptide), 
immuno-signals of the anti-Ptc-ICD7 (1420-1434) antibody (at a final concentration of 
5.5 nM IgG) in the nucleus of C3H10T1/2 cells were completely abolished (c). The 
nuclear immunosignals in embryonic primary cells were abolished with the 0.6 M 
antigenic peptide competition (g). Immuno-staining in green and Hoechst DNA stain in 





Figure 7. Schematic representation of the Tet-On Advanced system 
The promoter activity was controlled under the concentration of doxycycline (Dox). In 
the absence of Dox, this system kept the transcription of Ptc1 ICD7 at basal level (a). 
The binding of Dox with the Tet-On promoter stimulate Ptc1 ICD7 expression (b). 
 
Figure 8. The band pattern of Ptc1 ICD7 had the variation by Dox concentration 
Immuno-blotting of Ptc1 ICD7 with the final concentration of Dox 0, 0.01, 0.1, 1 
g/ml. showed the variation of the band pattern in the signal of ICD7. C-terminal 
ICD7 fragments were detected by anti-FLAG antibody, and anti-actin immunoblots 
were used as loading control. 
 
Figure 9. The cellular localization of Ptc1 ICD7 is accompanied with its protein 
expression level 
Immunostaining of Ptc1 ICD7 with the final concentration of Dox 0 or 1 g/ml. 
Immunostaining in green and Hoechst DNA stain in blue (b, d, f, h). Scale bar, 20 mm. 
 
Figure 10. Ptc1 ICD7 promoted the nuclear transportation of Gli1  
Immunostaining of Ptc1 ICD7 with the final concentration of Dox 0 or 1 g/ml. The 
anti-S antibody stain in green, the anti-FLAG stain in red and Hoechst DNA stain in 
blue (b, d, f, h). Scale bar, 20 mm. 
 
Figure 11. Schematic of a novel pathway which is in depends on Shh signaling 
(a) The model of Ptc1 ICD7 transporting to the nucleus. 
(b) Ptc1 ICD7 protein expression in high level could not transport to the nucleus (left 

























































































































CHAPTER 2: The C-terminal cytoplasmic tail of hedgehog receptor 
Patched1 is a platform for E3 ubiquitin ligase complexes 
 
Summary 
 The Sonic hedgehog (Shh) signaling pathway plays a crucial role in cell 
proliferation and differentiation via Patched1 (Ptc1), a 12-pass transmembrane receptor 
protein. The C-terminal cytoplasmic tail of Ptc1 can be cleaved to release the 7th 
intracellular domain (ICD7), whose function is still unclear. In this study, I found that 
the ICD7 fragment of Ptc1 associates with polyubiquitinated species. Using mass 
spectrometry, I identified a cluster of E3 ubiquitin ligase complex as novel Ptc1 
ICD7-binding proteins. In particular, Ptc1 ICD7 interacted with most components of 
the Cullin-2 (CUL2)-based E3 ligase complex, including TCEB1 (EloC), TCEB2 
(EloB), ZYG11B and CUL2 itself. To address the significance of CUL2-based E3 
ligase in Ptc1 function, I examined the effects of CUL2 knockdown on Shh-induced 
osteoblast differentiation in the undifferentiated mesenchymal cell line C3H10T1/2. 
Indeed, knockdown of CUL2 abolished the Shh-induced cell differentiation. These 
results suggest that CUL2-based E3 ligase complex may play a role in Shh- and 





 The Sonic hedgehog (Shh) signaling pathway regulates diverse processes 
involved in stem cell growth, maintenance and differentiation [Tabata and Kornberg, 
1994; Ingham and McMahon, 2001]. This pathway involves two key proteins, the Shh 
receptor Patched1 (Ptc1) and a downstream oncogenic transcription factors, Gli1, Gli2, 
and Gli3. In the absence of Shh, Ptc1 represses Gli-dependent transcription through 
indirect inhibition of another transmembrane protein, Smoothened. Binding of Shh to 
Ptc1 alleviates this repression, allowing activation of the Gli-mediated cell 
differentiation pathway [Marigo et al., 1996; Ingham et al., 2000]. In Drosophila, 
hedgehog (hh) and patched (ptc) specify cell fate in the developing embryo and along 
the anterior/posterior (A/P) axis of the adult wing [Tabata and Kornberg, 1994; Ingham 
and McMahon, 2001; Stone et al., 1996; Varjosalo and Taipale, 2007; Briscoe, 2004]. 
It was reported that malfunction of Ptc leads to embryonic lethality, indicating that Ptc 
is essential for the initial development of vertebrates and invertebrates, whereas ptc 
overexpression inhibits Hh signaling, reducing gene expression and affecting cell 
differentiation [Johnson et al., 1995].  
 Ptc1 is a 12-pass transmembrane (TM) protein with two sets of (1+3+2) 
membrane-spanning domains [Marigo et al., 1996; Stone et al., 1996]. Biochemical 
analysis of the Ptc1 protein has revealed important roles for the extracellular domains 
of Ptc1 in accepting its ligand, Shh. However, the function of its intracellular domain 
remains largely obscure. The human homolog of Ptc1, PTCH1, is a product of a tumor 
suppressor gene, and inactivating mutations in PTCH1 occur in sporadic and inherited 
forms of the common skin tumor basal cell carcinoma (BCC) [Gailani et al., 1996; 
Hahn et al., 1996; Johnson et al., 1996; Wolter et al., 1997; Goodrich et al., 1997; 
Wetmore et al., 2000] and in brain tumor [Vorechovsky et al., 1997; Xie et al., 1997]. 
Several oncogenic mutations of PTCH1 map to the 7th and largest intracellular domain 
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(designated in this paper as Ptc1 ICD7) of the C-terminal cytoplasmic tail of 
mammalian Ptc1, [Gailani et al., 1996; Lench et al., 1997; Makino et al., 2001; Boutet 
et al., 2003; Savino et al, 2004; Koike et al., 2002]. For example, a polymorphic 
variation of Ptc1 ICD7 has been shown to be essential for susceptibility to 
H-ras-induced squamous carcinoma [Wakabayashi et al., 2007]. Ptc1 ICD7 has been 
reported to be required for appropriate regulation of the Hh signaling pathway 
[Johnson et al., 2000; Lu et al., 2006], and deletion of the C-terminal 156 residues of 
Drosophila Ptc compromises Hh target gene repression [Johnson et al., 2000]. A 
spontaneous mouse mutant encoding a C-terminally truncated Ptc1 protein [Sweet et 
al., 1996; Nieuwenhuis et al., 2007] showed defects in the A-P polarity of the limb bud 
and increased expression of Gli target genes in white fat tissue [Li et al., 2008]. 
Furthermore, in the absence of Shh ligand, Ptc1 ICD7 recruits the caspase-activating 
complex as well as the E3 ubiquitin ligases NEDD4 and Itch to modulate apoptosis 
[Mille et al., 2009; Fombonne et al., 2012; Chen et al., 2014]. These findings highlight 
the functional importance of Ptc1 ICD7 in the Gli-mediated signal transduction 
pathway, although the exact mechanism of Ptc1 ICD7 remains to be determined.  
 In nematode Caenorhabditis elegans, the Gli-family Krüppel-like zinc finger 
transcription factor TRA-1 is indirectly regulated by TRA-2, a Ptc1-related 12-pass 
transmembrane protein, and activation of TRA-1 results in female-specific cell 
differentiation [Kuwabara and Kimble, 1992; Zarkower, 2006]. Genetic epistasis 
analysis suggests that tra-2 is an upstream regulator of three tra-1 suppressor genes, 
fem-1, fem-2, and fem-3 [Goodwin and Ellis, 2002]. Interestingly, Mehra et al. reported 
that the C-terminal cytoplasmic tail of TRA-2 (hereafter designated TRA-2 ICD7) 
directly interacts with the cytoplasmic protein FEM-3 and prevents male-specific 
TRA-1 suppression in the somatic tissues [Mehra et al., 1999; Lum et al., 2000]. This 
finding indicates that TRA-2 ICD7 has transcriptional regulatory activity for 
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controlling TRA-1-mediated cell differentiation by modulating FEM family proteins. It 
was recently revealed that three FEM proteins form a ubiquitin ligase complex for 
TRA-1 degradation [Starostina et al., 2007]. FEM-1 protein contains a von 
Hippel-Lindau (VHL) box that is essential for Cullin-2 (CUL2)-based ubiquitin ligase 
complex formation [Starostina et al., 2007]. This complex is known to contain Rbx1 or 
Rbx2 as a RING finger protein, CUL2 or CUL5 as a scaffold protein [Kile et al., 2002; 
Kamura et al., 2004], and the Elongin B and C complex used as an adaptor in the ECS 
complex.]. Subsequently, Starostina et al. showed that a CUL-2/FEM complex 
polyubiquitinates and targets the degradation of TRA-1, inducing male-specific cell 
differentiation [Starostina et al., 2007]. They also showed that FEM-2 and FEM-3 are 
cofactors that assemble with the FEM-1 complex to promote the efficient 
ubiquitination and degradation of TRA-1 [Starostina et al., 2007]. Thus, a series of 
results showed that CUL-2/FEM and TRA-2 ICD7 together mediate protein 
ubiquitination and thus control the final decision in the TRA-2/TRA-1-dependent cell 
differentiation pathway in the nematodes. However, possible contributions of the 
ubiquitin ligase complex to the mammalian counterpart of Ptc1 ICD7-Gli1 signaling 
pathway have not been adequately evaluated. 
 In this study, I analyzed the function of mammalian Ptc1 ICD7. To address 
this issue, I examined the binding protein profile of the Ptc1 ICD7 and found that it is 
associated with a number of ubiquitin-related proteins. I showed evidence that the 
CUL2-based complex is closely associated with Ptc1 in cell, both physically and 
functionally. These observations yield a novel hypothesis wherein the function of the 
Ptc1 cytoplasmic domain is linked with ubiquitinating enzymes. These results suggest 





Material and Methods 
Plasmid construction 
The cDNAs of human full length Ptc1 was amplified by RT-PCR from the 
transcript of HEK293 as described previously [Kagawa et al., 2011]. Using full-length 
Ptc1, the fragments of human Ptc1 ICD7 gene (encoding residues 1176-1447 of 
full-length Ptc1) were amplified by PCR, either as a wild-type or its mutated or 
truncated derivatives (Ptc1 ICD7 K1413R, N, C). These cDNAs were cloned into 
pCI-neo expression vector (Promega) that produces products containing three repeats 
of a FLAG tag sequence at the C-terminus. All of the cDNAs were verified by DNA 
sequencing before transfection experiments. 
 
Mammalian cell culture and transfection 
HeLa cell was cultured in Dulbecco’s modified Eagle’s medium (D-MEM, 
Sigma) supplemented with 10% heat-inactivated Calf Serum at 37 °C under a 5% CO2 
atmosphere. Mouse stem cell C3H10T1/2 was cultured as is HeLa cells except for the 
usage of 10% heat-inactivated Fetal Calf Serum. Transfection of the expression vectors 
to HeLa and C3H10T1/2 cells were performed with Hily-Max transfection reagent 
(Dojindo) according to the protocol supplied by the manufacturer. The total amount of 
plasmid DNA was adjusted to 1 g with an empty vector. At 24 hr after the 




 HEK293T cells were transfected with FLAG-tagged Ptc1 ICD7 expression 
vectors using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
instruction. At 24 h after transfection, the cells were treated with 5M MG132 for 4 hr 
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and then were washed with PBS containing 20 mM N-ethylmaleimide (NEM) and 
lysed with lysis buffer (20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), pH 7.5, 150 mM NaCl, 20 mM NEM, 50 mM NaF, 1 mM Na3VO4, 0.5% 
digitonin, 1 mM phenylmethylsulfonyl fluoride (PMSF), 5 g/ml leupeptin, 5 g/ml 
aprotinin, and 3 g/ml pepstatin A) and cleared by centrifugation. The cleared lysate 
was incubated with anti-FLAG M2-agarose beads (Sigma-Aldrich) for 1 h, and the 
agarose resin were washed three times with wash buffer (10 mM HEPES, pH 7.5, 150 
mM NaCl, and 0.1% Triton X-100). The immunoprecipitants were eluted with a FLAG 
peptide (0.5 mg/ml; Sigma-Aldrich) dissolved in wash buffer [Araki et al., 2013; 
Natsume et al., 2002]. After concentration by TCA precipitation, the Ptc1 
ICD7-associated proteins were redissolved in guanidine hydrochloride and digested 
with lysyl endopeptidase (Lys-C; Wako Chemicals USA). All samples were analyzed 
on a direct nanoflow liquid chromatography system coupled to a time-of-flight mass 
spectrometer. The mass spectrometry and tandem mass spectrometry spectra were 
obtained in information-dependent acquisition mode and were queried against the 
NCBI nonredundant database with an in-house Mascot server (version 2.2.1; Matrix 
Science; Natsume et al., 2002) [Natsume et al., 2002]. Immunoprecipitates from cell 
extracts of cell transfected with FLAG-tagged empty vector were used as negative 
controls. Proteins that were identified at least three independent precipitation trials by 




For immunoprecipitation analysis, cultured cells were washed with ice-cold 
phosphate-buffered saline and lysed with immunoprecipitation (IP) buffer containing 
10 mM Tris-HCl, pH7.5, 150 mM NaCl, 5 mM EDTA, 1 % NP-40, 10 mM NEM, 25 
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M MG132 and protease inhibitor cocktail (EDTA free, Nacalai tesque). The lysate 
was sonicated for one second and centrifuged at 15,000 rpm for 15 min at 4 °C, and 
resulting supernatant was incubated with 2.5 l of anti-FLAG M2-agarose beads 
(Sigma), or 2.5 l of S-protein agarose beads (Novagen) for 30 min at 4 °C. After the 
beads had been washed five times with the IP buffer, the precipitated 
immunocomplexes were subjected to SDS-PAGE. 
For Western blot analysis, the whole cell lysate and immunoprecipitates were 
separated by SDS-PAGE and transferred onto PVDF membrane (GE Healthcare). The 
membrane was probed with specific antibodies as indicated and then incubated with 
horseradish peroxidase-conjugated antibody against mouse and rabbit immunoglobulin 
(GE Helthcare), followed by detection with ECL blotting detection reagents (GE 
Healthcare), or Clarity™ Western ECL Substrate (BIO-RAD). 
The following antibodies were used for immunological analyses in this study: 
anti FLAG polyclonal (Sigma), anti-FLAG M2 monoclonal (Sigma), anti-T7 tagR 
monoclonal (Novagen), anti-S tagR polyclonal (Santa Cruz), anti-S tagR monoclonal 
(Novagen), anti-Myc tag polyclonal (Upstate), anti-actin polyclonal (Sigma), 




For S-protein pull-down analysis, cells were washed with ice-cold 
phosphate-buffered saline and lysed with IP buffer. The lysates were sonicated for one 
second and centrifuged at 15,000× rpm for 15 min at 4°C, and the resulting 
supernatants were divided into half, and incubated with 2 L of S-protein agarose 
beads (Novagen) for 2 hr at 4°C. After the beads had been washed five times with the 
IP buffer, these precipitated complexes were subsequently subjected to SDS-PAGE. 
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Gel filtration analysis 
 Extracts of HeLa cells were subjected to gel filtration on a column of Hiprep 
16/60 (GE Healthcare) in buffer A (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM 
dithiothreitol) at a flow rate of 0.5 ml/min. Fractions of 2 ml were collected and 
concentrated using methanol/chloroform protein precipitation methods. Precipitated 
products were subjected to SDS-PAGE, followed by Western blotting. Gel Filtration 
Calibration kits (GE Healthcare) were used as molecular mass standard proteins for gel 
filtration. (Thyroglobulin; 669-kDa, Ferritin; 440-kDa and Conalbumin; 75-kDa). 
 
Preparation of Shh-N-conditioned media 
To prepare Shh-N-conditioned media, expression vector encoding full-length 
Shh with N-terminally-FLAG-tagged and C-terminally-S-tagged was transfected into 
HeLa cells. 24 hr after Shh-transfection, I confirmed the appearance of matured form 
of FLAG-tagged Shh (with the molecular weight of 19-kDa) in the culture media of 
HeLa cells. To remove non-processed form of Shh (45-kDa from with C-terminal S tag, 
possibly contaminated from damaged cells), I pre-clear the medium with S-agarose 
beads. 
 
Alkaline phosphatase (ALP) activity assay 
Cell lysates of C3H10T1/2 containing 2 g total protein were mixed with assay 
buffer (1 mM MgCl2, 50 mM Tris-HCl, pH 9.2) containing 2 mM p-nitrophenol 
phosphate as a substrate. After 15 min incubation at 37°C, the reaction was terminated 
by adding 0.45 M NaOH. The absorbance of p-nitrophenol liberated in the reactive 
solution at 405 nm was measured as an ALP activity. The relative ALP activity was 




Gene knockdown experiments 
C3H10T1/2 cells were transfected with 10 nM siRNA duplexes using 
LipofectamineR 2000 Transfection Reagent (Invitrogen). The transfection reagents 
were used in accordance with the instructions of manufactures. Cells were harvested at 
72 hr after the transfection, and subjected to western blotting and ALP assay. The 
siRNA target sequences specific for mouse zyg11b, cul2 and cul3 mRNAs 
corresponded to nucleotides zyg11b (559-577, 5'- GUAACAAGUGGAUCCAGCA -3'), 




DNA recombination experiments: The study was approved by the Research Ethics and 
Safety Committee of Tokyo Metropolitan University (approval number, 27-35). All 





The C-terminal half region of Ptc1 ICD7 is essential for its binding to 
polyubiquitinated proteins 
Because the ICD7 fragment of nematode TRA-2 has been linked with 
ubiquitin-mediated protein degradation [Shimada et al., 2006, Starostina et al., 2007], 
Kagawa investigated whether mammalian Ptc1 ICD7 also associates with ubiquitin in 
mammalian cells. To test this possibility, Kagawa expressed T7-tagged Ptc1 ICD7 
with HA-tagged ubiquitin (Ub) in HeLa cells with or without treatment with the 
proteasome inhibitor MG132 and T7-precipitates were blotted with anti-HA antibody. 
The results showed that Ptc1 ICD7 co-immunoprecipitated with polyubiquitinated 
moieties [Kagawa et al., 2011]. Thus, I determined the region of Ptc1 ICD7 required 
for interaction with polyubiquitinated species. A deletion mutant of Ptc1 ICD7 lacking 
the N-terminal half (containing C-terminal 142 residues of Ptc1 ICD7, designated N, 
Fig. 1a) co-precipitated polyubiquitinated proteins as efficiently as WT Ptc1 ICD7 (Fig. 
1b). In contrast, a mutant Ptc1 ICD7 with truncation of the C-terminal 142 amino acid 
residues (designatedC) did not bind polyubiquitinated proteins (Fig. 1b). Thus, the 
C-terminal region of Ptc1 ICD7 is essential for the interacting of Ptc1 ICD7 to 
polyubiquitinated moieties. 
 
Mass spectrometry analyses identified a series of E3 ligases as Ptc1 ICD7-binding 
proteins 
To investigate the molecular mechanism of the polyubiquitin association of 
Ptc1 ICD7, I used mass spectrometry (MS) to examine Ptc1 ICD7-binding proteins 
(total 81 independent Ptc1 ICD7-binding candidate proteins identified in this study are 
summarized in Table 1. Although links between Ptc1 and ubiquitin-related enzymes 
have scarcely been reported, except for the PY-motif-mediated NEDD4 family 
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interaction for lysosomal targeting [Lu et al., 2006], the LC-MS/MS experiments 
identified a number of ubiquitin-related molecules as potential collaborators of Ptc1 
ICD7 (Table 2). For, examples, I identified ZYG11B and TCEB1 as novel Ptc1 ICD7 
binding candidate proteins, both of which are reported as cofactors of CUL2-based, 
ECS-type E3 ligase [Okumura et al., 2012]. Another Ptc1 ICD7 binding protein, SKP1, 
is a core component of the CUL1-based SCF-type E3 complex [Skowyra et al., 1997]. 
Other proteins identified were PRPF19, a U-box type E3 ubiquitin ligase that is 
necessary for spliceosomal function in the nucleus [Song et al., 2010], and TRIM28, a 
tripartite motif (TRIM) family proteins (one of the subfamilies of the RING type E3 
ubiquitin ligases) [Hatakeyama, 2011]. Ubiquitin-specific protease USP15, a 
nuclear-cytoplasmic shuttling protein required for TGFβ and BMP responses as a 
de-ubiquitinating enzyme for receptor-activated SMADs [Inui et al., 2011], was also 
identified as a potential binding partner for Ptc1 ICD7. These proteins, as well as a 
number of proteasomal subunits, could be identified as cell endogenous proteins in the 
MS analyses using FLAG-tagged Ptc1 ICD7 fragments as baits, although Ptc1 ICD7 
itself is a highly stable protein. 
 
ZYG11B and PRPF19 are candidate E3 ligases that interact with Ptc1 ICD7 
To further verify the possible interaction between Ptc1 ICD7 and candidate 
proteins identified by MS, I directly examined their in cell interactions using 
immunoprecipitations. I co-expressed FLAG-tagged Ptc1 ICD7 and T7-/S-tagged 
candidate E3 ligases in HeLa cells, and precipitates were probed with the appropriate 
antibodies. The interaction between Ptc1 ICD7 with SKP1 was ambiguous, because 
they indeed co-precipitated in S-pull down experiments (Fig. 2a) but I failed to detect 
their association by FLAG immunoprecipitation (Fig. 2b). In the case of TRIM28, I 
could not detect its binding to Ptc1 ICD7 with either FLAG (Fig. 3a) or T7 
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immunoprecipitation (Fig. 3b). Thus, I excluded TRIM28 as a candidate Ptc1 
ICD7-binding protein. 
On the other hand, I found that anti-FLAG beads did indeed precipitate 
T7-tagged ZYG11B (Fig. 4a) and PRPF19 (Fig. 5a) with FLAG-tagged Ptc1 ICD7. 
Furthermore, the S-agarose precipitations confirmed the stable associations of either 
S-tagged ZYG11B (Fig. 4b) or PRPF19 (Fig. 5b) with FLAG-tagged Ptc1 ICD7. These 
results suggest that both PRPF19 and ZYG11B are highly probable candidate E3 
ligases that interact with Ptc1 ICD7. I subsequently focused on ZYG11B because 
TCEB1, another ubiquitin-related protein identified by the MS analyses (Table 2), was 
reported to collaborate with ZYG11 as a single ECS-type E3 ubiquitin ligase complex 
[Vasudevan et al., 2007] whose function in the Shh-dependent signaling pathway 
remains unclear. 
 
The CUL2-Elongin-based ECS complex is a novel Ptc1 ICD7-associated E3 ligase 
ZYG11 was recently reported to be a substrate-specific receptor module of 
CUL2-based E3 ubiquitin ligases [Vasudevan et al., 2007]. CUL2-based ligases 
include stable subunits called Elongin C (TCEB1) and Elongin B (TCEB2) [Lonergan 
et al., 1998]. In the present study, I found that TCEB1 co-precipitated with Ptc1 ICD7 
(Fig. 6a), as suggested by the MS analysis (Table 2). However, the MS analysis with 
Ptc1 ICD7 failed to identify TCEB2 and any cullin family proteins, which are probable 
scaffold proteins for the ZYG11B-Elongin B/C complex [Vasudevan et al., 2007]. Thus, 
I performed further immunoprecipitation analyses with these proteins. 
I found evidence that FLAG-tagged Ptc1 ICD7 was indeed associated with 
Myc-tagged TCEB2 (Fig. 6b). T7-tagged CUL2 was also co-precipitated with 
FLAG-tagged Ptc1 ICD7 (Fig. 6c). To verify whether Ptc1 ICD7 binds to the 
ZYG11B-based complex, we performed size-exclusion chromatography analysis of 
50 
 
cell extracts that expressing TCEB1, TCEB2, ZYG11B, CUL2 and Ptc1 ICD7. As 
shown in Fig. 8d, I found that TCEB1, TCEB2, ZYG11B and Ptc1 ICD7 proteins were 
eluted in almost identical fractions of estimated molecular weight of 500-kDa 
(fractions 16 to 21), suggesting that these proteins are assembled into a large complex 
in the cells, although a part of the ZYG11B protein is incorporated in higher molecular 
weight complexes as well (fractions 1 to 12). A part of CUL2 protein also was eluted in 
higher molecular weight fractions (Fig. 6d, fraction 1 to 15), suggesting that CUL2 
protein may have one or more other functions independently of the Ptc1 ICD7 and 
TCEB1/2. However, I show that at least a part of CUL2 protein does indeed elute with 
Ptc1 ICD7 in identical fractions as well as TCEB1/2 (Fig. 6d, fractions 16 to 21), 
supporting the idea that CUL2-based E3 ligase complex are associated with Ptc1 ICD7 
in the cell. These results suggest that Ptc1 might be linked to a CUL2-based ECS-type 
E3 ubiquitination enzyme complex composed of CUL2, ZYG11B, TCEB1 and TCEB2 
as an authentic ECS complex (Fig. 6e). Another cullin-family protein, CUL1 and 
CUL3, also co-precipitated with Ptc1 ICD7, albeit with very weak interaction in the 
case of CUL1 (Fig. 7c). In the case of CUL1-linked subunit -TRCP, its 
coprecipitation with anti-FLAG Ptc1 ICD7 was apparent (Fig. 7a), while Ptc1 ICD7 
was hardly co-precipitated with anti-T7--TRCP (Fig. 7b). The significance of the 
CUL1--TRCP associations will be further examined elsewhere. 
 
The C-terminal region of Ptc1 ICD7 is essential for its association with the 
CUL2-based ubiquitin ligase complex 
I next determined the region of Ptc1 ICD7 required for its interaction with 
ZYG11B. A deletion mutant form of Ptc1 ICD7 lacking the N-terminal half (Fig. 1a) 
co-precipitated ZYG11B as efficiently as did WT Ptc1 ICD7 (Fig. 6f, N). In contrast, 
a C-terminally truncated Ptc1 ICD7 did not bind ZYG11B (Fig. 6f, C). Thus, the 
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C-terminal region of Ptc1 ICD7 is essential for its binding to ZYG11B, as is the case in 
the polyubiquitinated substrates associations (Fig. 1a). 
ZYG11B is a multi-domain protein with von Hippel-Lindau (VHL)-box, 
leucine-rich repeat motif (LRR) and armadillo helical domain (ARM) (Fig. 8a). To 
determine the region of ZYG11B required for the interaction with Ptc1 ICD7, I 
expressed a series of deletion constructs of ZYG11B in HeLa cells (Fig 8a, b). The 
results showed that deletions of von Hippel Lindau box (VHL), leucine-rich repeat 
(LRR) and Armadillo repeat (ARM) domains did not preclude the ZYG11B 
proteins interaction for Ptc1 ICD7 (Fig. 8b). Since I found a high homology region in 
downstream of Armadillo repeat (evolutionally conserved in human, mouse and 
nematodes), I prepared ARMp protein lacking this conserved sequence. Neither 
deletions of this conserved sequence (ARMp) nor other non-conserved sequences 
(1,2 and 3) abolished Ptc1 ICD7 complex formations, suggesting that multiple 
part of ZYG11B protein might participate in their complex formation. (Fig. 8b, c, d). 
 
CUL2-based ubiquitin ligase modulates Shh-induced cell differentiation 
The contributions of the CUL2/ZYG11B-based E3 ubiquitin ligase to the 
Shh-signaling pathway have not previously been addressed. Because Ptc1 is an 
essential mediator of the Shh signaling pathway, I next explored whether CUL2-based 
E3 ubiquitin ligase contributes to Ptc1-mediated cellular differentiation. C3H10T1/2 is 
an undifferentiated mesenchymal cell that can differentiate into alkaline phosphatase 
(ALP)-positive osteoblasts in response to Shh stimulation [Kinto et al., 1997; 
Arosarena et al., 2011]. In this cell line, I suppressed the expression of endogenous 
CUL2 by using its specific siRNA and examined the effects on the Ptc1-mediated 
regulation of ALP activity. Knockdown of CUL2 greatly reduced Shh-stimulated 
osteoblast differentiation (Fig. 9, compare column 2 and 6), while CUL2 knockdown 
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slightly stimulated ALP activity in the absence of Shh (Fig. 9, compare column 1 and 
5). As a result, it was suggested that Shh-induced ALP activation was completely 
abolished in the case of CUL2 knockdown (Fig. 9, compare column 5 and 6). 
Knockdown of ZYG11B showed a similar tendency with reduced efficacies (Fig. 9, 
compare column 2 and 4 as well as column 1 and 3). In the case of CUL3 knockdown, 
ALP activity was reduced regardless of Shh-treatment (Fig. 9, column 7 and 8). These 
results suggest an essential role for CUL2-based complex in the activation of 
Shh-induced cell differentiation. This is the first identification of a link between 






A previous study reported that suppression of RPN-10, a proteasomal 
polyubiquitin receptor subunit, modulates the activity of TRA-2 and its downstream 
Gli-family transcriptional factor TRA-1 in C. elegans [Shimada et al., 2006], 
indicating that the ubiquitin pathway is indispensable for the TRA-2-mediated cell 
differentiation pathway. Several studies also suggested that the ICD7 fragment of 
nematode TRA-2 is a scaffold of CUL-2-based ubiquitin E3 ligase [Starostinaet al., 
2007]. Although C. elegans TRA-2 protein does not have a genuine orthologue in 
mammals, and no homolog of vertebrate Shh has been identified in nematodes, TRA-2 
and mammalian Ptc1 share several common characteristics. For examples, the amino 
acids identity and similarity of ICD7 between nematode TRA-2 and mammalian Ptc1 
are 29% and 55%, respectively [Kagawa et al., 2011]. In addition, ICD7 of both 
TRA-2 and Ptc1 are cleaved to form soluble fragments that can be localized in the 
nucleus [Lumet al., 2000; Kagawa et al., 2011; Shimada et al., 2006]. Furthermore, 
both TRA-2 and Ptc1 indirectly regulate an orthologous transcriptional factor, TRA-1 
and Gli1, respectively, to modulate cell differentiation. TRA-2 ICD7 was reported to 
associate with CUL-2-based ubiquitin ligase [Starostinaet al., 2007], whereas the 
relationship between mammalian Ptc1 ICD7 and CUL2 is poorly understood. To 
investigate the possible ubiquitin-mediated control of mammalian Ptc1, as suggested 
for TRA-2 ICD7 with the FEM E3 complex in nematodes [Starostinaet al., 2007], I 
focused on the intracellular domain of mammalian Ptc1 protein. The LC-MS/MS 
analysis identified a number of cell endogenous E3 ubiquitin ligases as candidate Ptc1 
ICD7-associated proteins (Table 2). The immunoprecipitation and size-exclusion 
chromatography analyses also supported their associations, especially in the case of 
ZYG11B/CUL2 ECS-type complex.  
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Conjugation of ubiquitin moieties is important for both lysosomal targeting 
and/or proteasomal degradation, depending upon the substrate proteins and the nature 
of the ubiquitination [Bonifacino et al., 2003; Hicke and Dunn, 2003; Elsasser and 
Finley, 2005; Lévy et al., 2005]. Ubiquitination of membrane protein is crucial for 
effective down-regulation of plasma membrane receptors and transporters [Bonifacino 
et al., 2003; Hicke and Dunn, 2003; Lévy et al., 2005; Polo et al., 2002]. For example, 
ubiquitination at the C-terminal ICD domain of the cystic fibrosis transmembrane 
conductance regulator, another class of 12-pass transmembrane domain proteins, 
modulates the recycling and cell surface stability of the protein [Sharma et al., 2004]. 
Ubiquitin-binding adaptor proteins, including Hrs and STAM, play critical roles in the 
retrieval of ubiquitinated cargo for lysosomal degradation at sorting endosomes 
[Raiborg and Stenmark, 2002]. In the case of Drosophila Patched, Lu et al. previously 
reported that a PY motif in Patched C-terminal domain (i.e. ICD7) is responsible for 
direct interaction with NEDD4, a HECT domain ubiquitin ligase with a WW domain, 
and this interaction stabilizes Patched [Lu et al., 2006]. Kagawa found in the present 
study that Ptc1 ICD7 co-immunoprecipitates with polyubiquitinated species. However, 
this association should be distinct from the NEDD4-dependent polyubiquitination of 
Ptc1 because ICD7-associated polyubiquitinated species are proteasomal - but not 
lysosomal - substrates [Kagawa et al., 2011]. In addition, the mutational experiments 
suggested that the single lysine residue within the Ptc1 ICD7 fragment was dispensable 
for polyubiquitin association [Kagawa et al., 2011], suggesting that their interaction is 
not covalently modified. I speculate that Ptc1 ICD7 may provide a platform for 
CUL2-based ubiquitin ligase complex. It has been reported that mouse FEM1 homolog 
(FEM1B), another CUL2-based ubiquitin ligase, interacts with and polyubiquitinates 
Gli1 [Gilder et al., 2013], but Mr. Demizu was able to not detect an association of 
polyubiquitinated Gli1 with Ptc1 ICD7 (unpublished observations). The identities of 
55 
 
the polyubiquitin conjugates on the Ptc1 ICD7 complex remain to be determined, and 
further examination will be necessary to clarify this point. 
Although the biological significance of Ptc1 ICD7 has not been adequately 
examined, several previous reports implied that the Ptc1 ICD7 might be crucial for the 
control of Gli-family transcription factors [Makino et al., 2001; Wakabayashi et al., 
2007; Johnson et al., 2000; Lu et al., 2006; Nieuwenhuis et al., 2007; Kagawa et al., 
2011]. Indeed, single amino acid substitutions of Ptc1 in the ICD7 region have been 
associated with activation of Shh pathway in several human cancers, including basal 
cell carcinoma [Varjosalo and Taipale, 2007; Lench et al., 1997; Koike et al., 2002; 
Ping et al., 2001; Lindstrome et al., 2006]. The current findings provide a novel 
perspective, namely, that Ptc1 ICD7-binding CUL2 complex may play biological roles 
in the Shh signaling pathway (Fig. 9). Several interesting questions remain. For 
example, how do these E3 enzymes modulate the Shh signaling and what is the 
substrate? In addition, does ubiquitination of Ptc1 ICD7-associated substrates 
modulate their nuclear-cytoplasmic localization? Challenges for the future will be to 
determine the physiological roles of nuclear Ptc1 ICD7 in the regulation of gene 
transcription and modification of cell differentiation/tumor suppression. Further 
detailed investigation of these points will be necessary to elucidate the physiological 






Table 1. A full list of Ptc1 ICD7 associated proteins identified by mass 
spectrometry 
FLAG-tagged Ptc1 ICD fragments (either N-terminally- and C-terminally-tagged) 
were expressed in HeLa cells, and FLAG-precipitates were subjected to 
mass-spectrometer. Immunoprecipitates from cell extracts of cell transfected with 
FLAG-tagged empty vector were used as negative controls. Proteins that were 
identified at least three independent precipitation trials by two or more peptides with a 
peptide expectation value of P < 0.05 were considered as reliable identifications. 
 
Table 2. Ptc1 ICD7-associated proteins that were suggested to be linked with 
ubiquitin 
Mass spectrometry analysis of proteins co-precipitated with Ptc1 ICD7 revealed a 










Table 2. Ptc1 ICD7 associated proteins that were suggested to be linked 




Figure 1. Polyubiquitinated proteins co-precipitated with Ptc1 ICD7 
(a) Schematic representation of the T7-tagged Ptc1 ICD7 fragments used in this study. 
Wildtype (WT), fragments with residues 1176-1305 (C) and residues 1306-1447 (N) 
of Ptc1. 
(b) The C-terminus of Ptc1 ICD7 is essential for co-precipitation of polyubiquitinated 
proteins. A series of Ptc1 ICD7 fragments were immunoprecipitated with anti-FLAG 
antibody, and precipitates were probed with anti-Myc antibody to detect Myc-tagged 
polyubiquitin moieties. Note that poly-ubiquitinated species co-precipitated with Ptc1 
ICD7 regardless of the tag-species of ubiquitin used. 
 
Figure 2. Immunoprecipitation experiments with E3 ligase components SKP1 
FLAG-tagged Ptc1 ICD7 were co-expressed with S-tagged SKP1 in HeLa cells. To 
examine their interaction, S-precipitates were probed with anti-FLAG M2 antibody (a). 
FLAG-immunoprecipitates form cell lysates were probed with either anti-S antibody 
(b). Two distinct alternative splicing products of SKP1 are described as 1 and 2 (a, b). 
 
Figure 3. Immunoprecipitation experiments with E3 ligase components TRIM28 
FLAG-tagged Ptc1 ICD7 were co-expressed with T7-tagged in HeLa cells. To 
examine their interaction, FLAG-immunoprecipitates form cell lysates were probed 
with anti-T7 (a) antibody. T7-immunoprecipitates were probed with anti-FLAG M2 
antibody (b).  
 
Figure 4. Ptc1 ICD7 associates with ZYG11B  
FLAG-tagged Ptc1 ICD7 were co-expressed with ZYG11B (a, b) (either N-terminally 
T7-tagged or C-terminally S-tagged) in HeLa cells. To detect their protein interaction, 
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FLAG-immunoprecipitates form cell lysates were probed with anti-T7 antibody (a). 
S-precipitates were probed with anti-FLAG M2 antibody (b).  
 
Figure 5. Ptc1 ICD7 associates with PRPF19 
FLAG-tagged Ptc1 ICD7 were co-expressed with PRPF19 (a, b) (either N-terminally 
T7-tagged or C-terminally S-tagged) in HeLa cells. To detect their protein interaction, 
FLAG-immunoprecipitates form cell lysates were probed with anti-T7 antibody (a). 
S-precipitates were probed with anti-FLAG M2 antibody (b).  
 
Figure 6. The Ptc1 ICD7 complex includes most components of the CUL2-based 
E3 ubiquitin ligase 
FLAG-tagged Ptc1 ICD7 and subunits of CUL2-based E3 ligase were expressed in 
HeLa cells. FLAG-immunoprecipitates form cell lysates were probed with the 
appropriate antibodies as indicated to detect their interactions. TCEB1 and TCEB2 
(N-terminally Myc-tagged, a and b), CUL2 (N-terminally T7-tagged, c) and ZYG11B 
(N-terminally T7-tagged, f). Extracts of HeLa cells that expressing FLAG-tagged Ptc1 
ICD7, S-tagged ZYG11B, Myc-tagged TCEB1 and TCEB2 were subjected to gel 
filtration using Hiprep 16/60 column (d). Eluates were precipitated by 
methanol/chloroform and then subjected to Western blot analysis with indicated 
antibodies. Elution points of molecular mass standard proteins were indicated. 
Schematic model of CUL2-based ubiquitin ligase associated with Ptc1 ICD7 (e). The 
C-terminus of Ptc1 ICD7 is essential for ZYG11B association (f). A series of Ptc1 
ICD7 fragments were immunoprecipitated with anti-FLAG antibody, and precipitates 




Figure 7. Immunoprecipitation experiments with CUL1 and CUL3-based E3 
ligase components 
FLAG-tagged Ptc1 ICD7 were co-expressed with T7-tagged -TRCP, CUL1 and 
CUL3 in HeLa cells. To examine their interaction, FLAG-precipitates (a, c) or 
T7-precipitates (b) were probed with anti-T7 or anti-FLAG M2 antibodies. an asterisk 
indicate non-specific signals derived from IgG. 
 
Figure 8. Neither VHL-box, LRR and Armadillo repeat of ZYG11B is exclusively 
required for ZYG11B interaction with Ptc1 ICD7 
(a) Schematic of the ZYG11B-deletion mutant proteins used in this experiment. 
Numbers denote the corresponding amino acid numbers of mouse ZYG11B. Deletion 
of von Hippel Lindau box (VHL), leucine-rich repeat (LRR) and Armadillo repeat 
(ARM). Serine substitution of ZYG11B at Leu18 was indicated by L18S.  
(b) FLAG-tagged Ptc1 ICD7 and a series of T7-tagged ZYG11B mutants were 
expressed in HeLa cells. FLAG-immunoprecipitates were probed with T7 antibody to 
detect their interactions. 
 
Figure 9. CUL2-based E3 ubiquitin ligase complex is critical for Shh-induced 
stem cell differentiation 
Knockdown of CUL2 completely suppressed Shh-induced osteoblast differentiation of 
mesenchymal stem cell C3H10T1/2. Knockdown of ZYG11B also weakened Shh 
responses. Alkaline phosphatase (ALP) activity was measured as a maker of osteoblast 
differentiation. The ALP phosphatase value of untreated C3H10T1/2 cell was used as 
the standard (100%). Experiments were performed more than three independent cell 
cultures and use all measured data, and error bars represent the standard deviation (SD). 













































 Chapter 1 described that the 7th intracellular domain (ICD7) of Patched1 
(Ptc1) localized to the nucleus, while the mechanism for its nuclear transportation was 
unclear. In this chapter, I focused on a protein that might function as an adaptor for the 
nuclear anchoring of Ptc1. AKIP1 is reportedly a candidate protein that interacts with 
Ptc1 ICD7. In a previous study, Mr. Tamaki investigated the interaction of ICD7 with 
AKIP1 in cells by immuno-precipitation experiments. In this study, I revealed that the 
essential region of ICD7 for its interaction with AKIP1 was domain II. To evaluate the 
importance of the interaction between ICD7 and AKIP1, I examined Gli activity in 
C3H10T1/2 cells. As a result, not only over-expressed AKIP1 but also akip1 
suppression by small interfering RNA (siRNA) increased Gli activity. Moreover, 
over-expressed Ptc1 ICD7 suppressed the increase in Gli activity induced by akip1 
knockdown. To investigate if the nuclear localization of ICD7 might be influenced by 
AKIP1, I performed an immuno-staining experiment under akip1 siRNA condition, 
and found that the ICD7 fluorescence nuclear signal was abolished. This result 
suggests that the nuclear localization of Ptc1 ICD7 requires AKIP1 protein, and AKIP1 





 Chapter 1 described that the 7th intracellular domain (ICD7) of Patched1 
(Ptc1) localized to the nucleus, but the mechanism of its nuclear transportation was 
unclear. In this study, it is focused on a protein that functions as an anchor in the 
nucleus. To elucidate the mechanism of ICD7 cleavage, Mille et al. conducted 
comprehensive yeast two-hybrid screening using ICD7 as bait [Mille et al., 2009]. 
Some candidate proteins were reported, but they only investigated DRAL further. 
Indeed, they showed clearly that DRAL collaborates with Ptc1 ICD7 for apoptotic 
control. Mille et al. also indicated that Ptc1 ICD7 was cleaved by caspase-9 in human 
embryonic kidney (HEK293) cells. However, the mechanism by which ICD7 is 
cleaved was largely unknown. It is considered that Ptc1 ICD7 binding proteins 
contribute to the cleavage and nuclear transportation of ICD7. 
 A kinase interacting protein AKIP1 is one of the reported candidate binding 
protein of Ptc1 ICD7. AKIP1 was identified as a breast cancer associated gene (BCA3) 
product [Kitching et al., 2003], and is expressed highly in breast cancer cells. In further 
study, it was reported that AKIP1 possesses a variety of roles in the inflammatory 
response and cell growth [Gloire et al., 2006; Agarwal et al., 2005; Hayden et al., 
2006]. AKIP1 enhanced the activity of the NF-B transcription factor by confining 
RELA, a subunit of NF-B, to the nucleus. Phosphorylation of RELA was promoted 
by cAMP-dependent protein kinase catalytic subunit alpha, and AKIP1 consequently 
controlled the cAMP protein phosphorylation signaling pathway [Sastri et al., 2005; 
Gao et al., 2010]. 
 To determine whether Ptc1 ICD7 interacts with AKIP1 in mammalian cells, 
both I and Mr. Tamaki expressed FLAG-tagged ICD7 and T7-tagged AKIP1 in HeLa 
cells. By immunoprecipitation with HeLa cell extracts, ICD7 was found to bind with 
AKIP1. An experiment using deletion mutants narrowed the interacting region of ICD7 
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(residues 1377-1387) for AKIP1. However, it was unclear whether these 10 amino 
acids are sufficient for ICD7 binding with AKIP1. This candidate region of ICD7 for 
its interaction with AKIP1 apparently corresponds to domain II. Domain II in Ptc1 
ICD7 was defined by Kawamura et al., whose sequence was conserved from 
invertebrate to vertebrate Ptc1 [Kawamura et al., 2008]. In Drosophila, Ptc domain II 
was reportedly required for trimer formation. However, domain II has not been 
determined yet in mammals. 
In this study, to examine whether this region is important for the binding of 
ICD7 with AKIP1, I created a construct in which these 10 amino acids in ICD7 domain 
II were deleted. Moreover, I examined the role of the interacting region of ICD7 with 




Material and Methods 
Plasmid construction 
The cDNAs of human Ptc1 was amplified by RT-PCR from the transcript of 
HEK293 as described previously [Kagawa et al., 2011]. Using full-length Ptc1, the 
fragments of human Ptc1 ICD7 gene (encoding residues 1176-1447 of full-length 
Ptc1) were amplified by PCR. These cDNAs were cloned into pCI-neo expression 
vector (Promega) that produces products containing three repeats of a FLAG tag 
sequence at the C-terminus. All of the cDNAs were verified by DNA sequencing 
before transfection experiments. 
 
Mammalian cell culture and transfection 
HeLa cell was cultured in Dulbecco’s modified Eagle’s medium (D-MEM, 
Sigma) supplemented with 10% heat-inactivated Calf Serum at 37 °C under a 5% CO2 
atmosphere. Mouse stem cell C3H10T1/2 was cultured as is HeLa cells except for the 
usage of 10% heat-inactivated Fetal Calf Serum. Transfection of the expression vectors 
to HeLa and C3H10T1/2 cells were performed with Hily-Max transfection reagent 
(Dojindo) according to the protocol supplied by the manufacturer. The total amount of 
plasmid DNA was adjusted to 1 g with an empty vector. At 24 hr after the 




For immunoprecipitation analysis, cultured cells were washed with ice-cold 
phosphate-buffered saline and lysed with immunoprecipitation (IP) buffer containing 
10 mM Tris-HCl, pH7.5, 150 mM NaCl, 5 mM EDTA, 1 % NP-40, 10 mM 
N-ethylemaleimide, 25 M MG132 and protease inhibitor cocktail (EDTA free, 
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Nacalai tesque). The lysate was sonicated for one second and centrifuged at 15,000 
rpm for 15 min at 4 °C, and resulting supernatant was incubated with 2.5 l of 
anti-FLAG M2-agarose beads (Sigma), or 2.5 l of S-protein agarose beads (Novagen) 
for 30 min at 4 °C. After the beads had been washed five times with the IP buffer, the 
precipitated immunocomplexes were subjected to SDS-PAGE. 
For Western blot analysis, the whole cell lysate and immunoprecipitates were 
separated by SDS-PAGE and transferred onto PVDF membrane (GE Healthcare). The 
membrane was probed with specific antibodies as indicated and then incubated with 
horseradish peroxidase-conjugated antibody against mouse and rabbit immunoglobulin 
(GE Helthcare), followed by detection with ECL blotting detection reagents (GE 
Healthcare), or Clarity™ Western ECL Substrate (BIO-RAD). 
The following antibodies were used for immunological analyses in this study: 
anti FLAG polyclonal (Sigma), anti-FLAG M2 monoclonal (Sigma), anti-T7 tagR 
monoclonal (Novagen), anti-S tagR polyclonal (Santa Cruz), anti-S tagR monoclonal 
(Novagen), anti-Myc tag polyclonal (Upstate), anti-actin polyclonal (Sigma), 
HRP-conjugated anti-mouse IgG (GE Healthcare), HRP-conjugated anti-rabbit IgG 
(GE Healthcare). 
 
Alkaline phosphatase (ALP) activity assay 
Cell lysates of C3H10T1/2 containing 2 g total protein were mixed with assay 
buffer (1 mM MgCl2, 50 mM Tris-HCl, pH 9.2) containing 2 mM p-nitrophenol 
phosphate as a substrate. After 15 min incubation at 37°C, the reaction was terminated 
by adding 0.45 M NaOH. The absorbance of p-nitrophenol liberated in the reactive 
solution at 405 nm was measured as an ALP activity. The relative ALP activity was 




Gene knockdown experiments 
C3H10T1/2 cells were transfected with 10 nM siRNA duplexes using 
LipofectamineR 2000 Transfection Reagent (Invitrogen). The transfection reagents 
were used in accordance with the instructions of manufactures. Cells were harvested at 
72 hr after the transfection, and subjected to western blotting and ALP assay. The 
siRNA target sequences specific for mouse akip1 mRNAs corresponded to nucleotides 
akip1 (314-332, 5'- GAAUUCAUGGACUAUACUU -3'). 
 
Luciferase assay 
The reporter plasmids 8x3’Gli-BSd51LucII and 8xm3’Gli-BSd51LucII were 
constructed by placing eight copies of a Gli binding site element present in the mouse 
HNF-3b enhancer or a mutated version of it [Sasaki et al., 1997]. After cDNA 
transfection, HeLa cells were harvested and transcriptional activity of Gli1 was 
monitored by the Dual-LuciferaseR Reporter Assay System (Promega) according to the 
protocol supplied by the manufacturer. Normalization of transfection efficiencies was 
carried out using Renilla luciferase activities. All reporter assay experiments were 
repeated at least three times, and transfection was done in triplicate. Reporter plasmids 
8×3’Gli-BSd51LucII and 8×m3’Gli-BSd51LucII as well as Gli1 expression vector 




DNA recombination experiments: The study was approved by the Research Ethics and 
Safety Committee of Tokyo Metropolitan University (approval number, 27-35). All 





The interaction requires partial domain II sequences between Ptc1 ICD7 and 
AKIP1 
 To identify the region in Ptc1 ICD7 that is required for binding to AKIP1, in a 
previous study, C-terminal deleted mutants were used in immuno-precipitation 
experiments. Mr. Tamaki showed an interaction between the C-terminal 60 amino acids 
deletion mutant of ICD7 (designated 60) and AKIP1, while this interaction was not 
observed between 70 and AKIP1 (unpublished observations). To avoid unnecessary 
effects of over-deleting constructs, a new created mutant (designated as del DOM2), in 
which only the putative region for its interaction with AKIP1 was deleted (Fig. 1a). 
Immuno-precipitation demonstrated that del DOM2 did not interact with AKIP1, 
whereas ICD7 WT interacted with AKIP1 (Fig. 1b). This result showed the necessity 
of ICD7 residues 1377-1387 for its interaction with AKIP1. 
 
Exogenous AKIP1 enhances Gli1 activity independently of the Shh signaling 
pathway 
  To examine the role of the interaction between ICD7 and AKIP1, I tested 
Gli1 activity in C3H10T1/2 cells. In cells over-expressing IDC7, there was no 
difference compared with control cells in the luciferase assay (Fig. 2). Conversely, 
cells over-expressing AKIP1 showed increased Gli activity. This enhancement of Gli 
activity by AKIP1 was maintained when ICD7 or del DOM2 was co-expressed. This 
increased Gli activity promoted the over-expression of AKIP1 seemed to be 
independent of the interaction between ICD7 and AKIP1.  
 
Endogenous akip1 knockdown activates Gli1 activity 
 To investigate the effect of siRNA for akip1, immuno-blotting using an AKIP1 
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expression vector showed the suppressive effect of the siRNA. Transfection of HeLa 
cells with siRNA suppressed the expression of exogenous T7-tagged AKIP1 (Fig. 3a). 
To verify Gli activity, C3H10T1/2 cells were transfected with akip1 siRNA. 
Knockdown of akip1 increased Gli activity compared with control (Fig. 3b). 
Knockdown of akip1 also enhanced alkaline phosphatase (ALP) activity (Fig. 4), 
which is expressed by osteoblasts, and co-expression ICD7 suppressed the 
enhancement of ALP in the akip1 knockdown condition. These results suggested that 
the activation of Gli1 shown in Fig. 3b was involved in osteoblast differentiation.  
 
Nuclear localization of ICD7 requires AKIP1 
I examined whether AKIP1 affects the nuclear localization of ICD7 from what 
AKIP1 roles the anchoring PKA to the nucleus. An antibody specific to C-terminal 
Ptc1 ICD7 generated fluorescent signals in the nucleus (Fig. 5a-c). However, the 
nuclear localization signal of ICD7 was not detected following akip1 knockdown (Fig. 





To elucidate the localization mechanism of Ptc1 ICD7, I assessed the function 
of an ICD7-binding protein. AKIP1 was reported as a candidate ICD7-binding 
molecule in a yeast two-hybrid screen [Mille et al., 2009]. Indeed, in a previous study, 
Mr. Tamaki indicated that immuno-precipitation using mammalian cell extracts 
showed an interaction between ICD7 and AKIP1. Moreover, in this study, my domain 
II partial deletion mutant was used to investigate the critical region for its interaction 
with AKIP1. Domains I and II of Ptc1 ICD7 was defined as islands of high sequence 
conservation [Kawamura et al., 2008]. In Drosophila, Ptc exists as a trimer at domain 
II [Lu et al., 2006]; however, the role of domain II in mammalian Ptc1 ICD7 is unclear. 
AKIP1 binds to the C subunit of PKA at the carboxyl terminus of AKIP1 
[Sastri et al., 2005]. Deletion of the carboxyl terminus of AKIP1 abolished the nuclear 
localization of the activated endogenous C subunit [Sastri et al., 2005]. After RNAi 
knockdown of AKIP1 in breast cancer cells, Gao et al. observed that PKA-activating 
agents antagonized NF-B-dependent activation [Gao et al., 2010]. AKIP1 also 
regulates the interaction of p65 with PKAc and p65 phosphorylation [Gao et al., 2010]. 
PKA is as strong a negative regulator of the Shh pathway as Ptc1 or suppressor of 
fused Sufu [Tuson et al., 2011]. A recent study also described that PKA inactivation in 
mice is sufficient to cause the aberrant expansion of the stem cell compartment, 
resulting in the rapid formation of basal cell carcinoma-like lesions 
[Iglesias-Bartolome et al., 2015]. Heterotrimeric G-protein Gαs-PKA disruption 
promotes cell autonomous Shh pathway stimulation and Hippo signaling inhibition, 
resulting in the non-canonical activation of Gli and YAP1 [Iglesias-Bartolome et al., 
2015]. Fig. 3 shows the increase of endogenous Gli activity following akip1 
knockdown. Thus, AKIP1 suppression caused the activation of endogenous PKA C 
subunit, and hence Gli could have been upregulated by PKA indirectly (Figs. 3 and 4).  
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On the based that PKA is anchored to the nucleus by AKIP1, I examined 
whether Ptc1 ICD7 was also tethered to the nucleus. Immuno-staining showed the 
inhibition of the nuclear localization of ICD7 following akip1 knockdown. Thus, the 
nuclear localization of ICD7 requires AKIP1 protein, suggesting that AKIP1 transports 





Figure 1. Immuno-blotting for the interaction of Ptc1 ICD7 and AKIP1 
(a) Schematic representation of the FLAG-tagged Ptc1 ICD7 fragments used in this 
study. Wild -type: WT; partial deletion of domain II, residues 1377-1387: del DOM2. 
(b) Wild type (W) or del DOM2 (D) mutant form of FLAG-tagged Ptc1 ICD7 was 
immuno-precipitated from cell extracts. Immuno-blotting showed the interaction with 
T7-tagged AKIP1. To demonstrate binding between ICD7 and AKIP1, FLAG-tagged 
ICD7 and T7-tagged AKIP1 were co-expressed in HeLa cells. Immunoprecipitation 
revealed the interaction of ICD7 with AKIP1 in HeLa cell extracts. 
 
Figure 2. Luciferase-reporter assay reveals Gli1 activity 
In C3H10T1/2 cells, a dual-luciferase reporter assay was performed with a reporter 
construct consisting of eight copies of the Gli-binding site (8×3’ Gli-BS) or its mutated 
version (8×m3’Gli-BS) as a negative control. Normalization of transfection efficiency 
was performed using Renilla luciferase activity as an internal control. Experiments 
were performed more than three independent cell cultures and use all measured data, 
and error bars represent the standard deviation (SD). P < 0.01, by t-test. W: ICD7 
wild-type; D: del DOM2. 
 
Figure 3. akip1 knockdown affects the Gli1 activity 
(a) Immuno-blotting of akip1 knockdown by siRNA. Anti-actin in loading control. 
(b) Dual-luciferase reporter assay, in C3H10T1/2. Experiments were performed more 
than three independent cell cultures and use all measured data, and error bars represent 





Figure 4. Ptc1 ICD7 suppressed the ALP activity in activated by akip1 knockdown 
Knockdown of akip1 suppressed osteoblast differentiation of mesenchymal stem cell 
C3H10T1/2. Alkaline phosphatase (ALP) activity was measured as a maker of 
osteoblast differentiation. The ALP phosphatase value of untreated C3H10T1/2 cell 
was used as the standard (100%). Experiments were performed more than three 
independent cell cultures and use all measured data, and error bars represent the 
standard deviation (SD). P < 0.01, by t-test. 
 
Figure 5. The nuclear localization of ICD7 required AKIP1 
Immunostaining of anti-Ptc1 C-terminal antibody in the absence of akip1 siRNA (a). 
With siRNA showed abolished the nucleoplasm ICD7 (d). Immuno-staining in green, 


























 Patched1 (Ptc1) is a 12-pass transmembrane protein, roles as a receptor of 
Sonic hedgehog (Shh) signal. Extracellular largely domain of Ptc1 receives directly the 
morphogen Shh, regulates diverse processes involved in stem cell growth, maintenance 
and differentiation. Although Ptc1 has large intracellular domains, their functions were 
little investigated to date. In this thesis, I investigated that endogenous Ptc1 7th 
intracellular domain (ICD7) was subjected to cleavage, and translocated into the 
nucleus in Chapter 1. Using specific antibody, ICD7 was fragmented from full length 
Ptc1 in immuno-blotting experiments and the fluorescent signals were localized in the 
nucleus clearly. The transient nucleoplasm Ptc1 ICD7 affected the localization of Gli1. 
In Chapter 2 and 3, to examine the function of nucleoplasm Ptc1 ICD7, I focused on 
the binding proteins with ICD7. Mass spectrometry analyses identified a series of E3 
ligases as candidate Ptc1 ICD7-binding proteins, and indeed many proteins were 
interacted with ICD7 in mammalian cells in Chapter 2. Especially, the many 
components of CUL2 based E3 ligase complex, ZYG11B, TCEB1, TCEB2 and CUL2, 
were interacted with ICD7. I elucidated that CUL2 based ubiquitin ligase modulates 
Shh-induced stem cell differentiation. In Chapter 3, I examined the relationship Ptc1 
ICD7 with AKIP1, which is one of the component in NF-B pathway. It was showed 
that AKIP1 had the role as a suppressor to Gli1. In addition, AKIP1 were required for 
the nuclear localization of ICD7. 
 The important thing is that endogenous Ptc1 ICD7 are cleaved and ICD7 
fragments are transported to the nucleus in mammalian cell culture. To investigate the 
role of nuclear ICD7, candidate ICD7-binding proteins derived in mass spectrometry 
analysis were confirmed the interaction with transfected FLAG-tagged ICD7. 
Interaction of ICD7 with CUL2-based E3 ligase complex, including ZYG11B, TCEB1, 
and TCEB2, might promote a ubiquitination of ICD7-binding polyubiquitinated 
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protein. Identification of this substrate is expected by further research using C-terminal 
ICD7, which was remarked as C in Chapter 2. Interaction of Ptc1 ICD7 not only with 
CUL2 complex but also with CUL-1 complex, including SKP1 and -TRCP which are 
reportedly involved Gli1 activity, was supported that ICD7 affected the Gli1 nuclear 
localization. In the absence of AKIP1, the nuclear Ptc1 ICD7 was exported from the 
nuclear or was failure to import to the nuclear. Although the promoting Gli1 nuclear 
localization and the suppressing Gli1 activity by Ptc1 ICD7 are conflicting, these 
observations might be caused by the expression level of Ptc1 ICD7. Because Ptc1 
ICD7 interacted with a lot of proteins in HeLa cells, nuclear ICD7 fragments may 
assume multiple functions. 
 The nuclear localization of Ptc1 ICD7 give rise to doubts about the role of 
ICD7 in the nucleus. An example of a nuclear localization protein includes, but are not 
limited to, Gli1 in Shh signaling pathway. Gli1 and Gli2 role as an activator, and Gli3 
functions as a repressor in the nucleus. These three factors regulate the transcription for 
various biological events, such as development or cell proliferation, as the most 
downstream contents in Shh pathway. The localization of Gli family were one of the 
important element and hence influence the transcription of Gli-target genes as cyclin D, 
cyclin E, myc, gli1, and ptc1 [Katoh and Katoh, 2009; Kim et al., 2010]. In this study, 
intracellular location and activity of Gli1 were investigated, however, an association of 
Ptc1 ICD7 with Gli2 and Gli3 directly should be investigated. 
 This thesis suggests the existence of a novel alternative signaling pathway for 
mammalian Ptc1 that is mediated by the generation and nuclear translocation of ICD7 
fragments. Although the cleavage mechanism of ICD7 from full-length Ptc1 requires 
further investigation, I would like to propose that Ptc1 ICD7 function as a novel signal 
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